Details for New Drug Application (NDA): 202860
✉ Email this page to a colleague
NDA 202860 describes GENOSYL, which is a drug marketed by Vero Biotech Inc and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug. Additional details are available on the GENOSYL profile page.
The generic ingredient in GENOSYL is nitric oxide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nitric oxide profile page.
The generic ingredient in GENOSYL is nitric oxide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nitric oxide profile page.
Summary for 202860
| Tradename: | GENOSYL |
| Applicant: | Vero Biotech Inc |
| Ingredient: | nitric oxide |
| Patents: | 14 |
Pharmacology for NDA: 202860
| Physiological Effect | Vasodilation |
Medical Subject Heading (MeSH) Categories for 202860
Suppliers and Packaging for NDA: 202860
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GENOSYL | nitric oxide | GAS;INHALATION | 202860 | NDA | VERO BIOTECH, INC. | 72385-001 | 72385-001-01 | 216 L in 1 CARTRIDGE (72385-001-01) |
| GENOSYL | nitric oxide | GAS;INHALATION | 202860 | NDA | VERO BIOTECH, INC. | 72385-002 | 72385-002-01 | 216 L in 1 CARTRIDGE (72385-002-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GAS;INHALATION | Strength | 800PPM | ||||
| Approval Date: | Dec 20, 2019 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Feb 12, 2036 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Oct 20, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Aug 13, 2029 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Expired US Patents for NDA 202860
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | ⤷ Get Started Free | ⤷ Get Started Free |
| Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | ⤷ Get Started Free | ⤷ Get Started Free |
| Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | ⤷ Get Started Free | ⤷ Get Started Free |
| Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | ⤷ Get Started Free | ⤷ Get Started Free |
| Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
